Cetera Investment Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$144M Buy
1,193,872
+55,456
+5% +$6.4M 0.15% 117
2025
Q4
$120M Buy
1,138,416
+61,979
+6% +$5.82M 0.13% 134
2025
Q3
$90.3M Buy
1,076,437
+338,470
+46% +$27.9M 0.11% 180
2025
Q2
$58.4M Buy
737,967
+30,773
+4% +$2.45M 0.1% 205
2025
Q1
$63.5M Buy
707,194
+26,263
+4% +$2.45M 0.12% 172
2024
Q4
$67.7M Sell
680,931
-28,696
-4% -$2.96M 0.14% 148
2024
Q3
$80.6M Sell
709,627
-27,950
-4% -$3.32M 0.18% 117
2024
Q2
$91.3M Sell
737,577
-28,269
-4% -$3.64M 0.21% 94
2024
Q1
$101M Buy
765,846
+549,961
+255% +$67.8M 0.24% 82
2023
Q4
$23.5M Sell
215,885
-15,324
-7% -$1.59M 0.19% 99
2023
Q3
$23.8M Sell
231,209
-37,146
-14% -$4M 0.21% 91
2023
Q2
$31M Sell
268,355
-4,089
-2% -$464K 0.26% 64
2023
Q1
$29M Sell
272,444
-13,694
-5% -$1.48M 0.25% 74
2022
Q4
$31.7M Buy
286,138
+100,709
+54% +$10.3M 0.29% 64
2022
Q3
$16M Sell
185,429
-42,163
-19% -$3.76M 0.32% 63
2022
Q2
$20.8M Buy
227,592
+13,588
+6% +$1.2M 0.33% 55
2022
Q1
$17.6M Buy
214,004
+20,337
+11% +$1.6M 0.25% 78
2021
Q4
$14.8M Buy
193,667
+9,349
+5% +$745K 0.21% 98
2021
Q3
$13.8M Buy
184,318
+3,638
+2% +$277K 0.22% 98
2021
Q2
$14.1M Buy
180,680
+19,799
+12% +$1.47M 0.23% 99
2021
Q1
$11.8M Sell
160,881
-13,028
-7% -$961K 0.23% 94
2020
Q4
$13.6M Buy
173,909
+129,417
+291% +$9.9M 0.27% 79
2020
Q3
$3.52M Buy
44,492
+2,042
+5% +$160K 0.29% 85
2020
Q2
$3.13M Buy
42,450
+14,185
+50% +$1.07M 0.29% 89
2020
Q1
$2.08M Buy
28,265
+5,234
+23% +$411K 0.25% 112
2019
Q4
$2M Buy
23,031
+1,234
+6% +$101K 0.2% 130
2019
Q3
$1.75M Sell
21,797
-871
-4% -$69.8K 0.21% 125
2019
Q2
$1.81M Buy
22,668
+2,803
+14% +$215K 0.23% 113
2019
Q1
$1.57M Buy
19,865
+1,299
+7% +$97.2K 0.22% 114
2018
Q4
$1.36M Sell
18,566
-919
-5% -$64.9K 0.22% 121
2018
Q3
$1.31M Buy
19,485
+2,322
+14% +$148K 0.19% 131
2018
Q2
$993K Buy
17,163
+470
+3% +$26.5K 0.17% 149
2018
Q1
$865K Sell
16,693
-3,192
-16% -$172K 0.16% 158
2017
Q4
$1.07M Sell
19,885
-1,275
-6% -$70.7K 0.2% 134
2017
Q3
$1.29M Sell
21,160
-40
-0.2% -$2.42K 0.29% 92
2017
Q2
$1.29M Sell
21,200
-708
-3% -$43.1K 0.32% 85
2017
Q1
$1.32M Buy
21,908
+2,350
+12% +$143K 0.37% 81
2016
Q4
$1.1M Buy
19,558
+8,748
+81% +$512K 0.37% 81
2016
Q3
$640K Sell
10,810
-10,378
-49% -$607K 0.27% 104
2016
Q2
$1.17M Buy
21,188
+766
+4% +$40.8K 0.46% 61
2016
Q1
$1.03M Buy
20,422
+3,342
+20% +$164K 0.45% 59
2015
Q4
$863K Buy
+17,080
New +$861K 0.4% 69

Other funds holding MRK

Cetera Investment Advisers's MRK Position: Q1 2026 in Review

Cetera Investment Advisers increased its Merck (MRK) stake by 4.9% in Q1 2026, buying an estimated $6.4M and bringing the position to 1,193,872 shares worth $144M. The position accounts for 0.15% of the portfolio, ranked #117.

Cetera Investment Advisers first reported a position in MRK in Q4 2015 and has held it in 42 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cetera Investment Advisers held 1,193,872 shares of Merck worth $144M as of Q1 2026.
  • Cetera Investment Advisers bought 55,456 Merck shares in Q1 2026, an estimated $6.4M.
  • Merck made up 0.15% of Cetera Investment Advisers's portfolio in Q1 2026, its #117 holding.
  • Cetera Investment Advisers first reported a position in Merck in Q4 2015 and has held it in 42 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.